A citation-based method for searching scientific literature

Masahide Takahashi, Kumi Kawai, Naoya Asai. JMA J 2020
Times Cited: 11







List of co-cited articles
42 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Efficacy of Selpercatinib in RET-Altered Thyroid Cancers.
Lori J Wirth, Eric Sherman, Bruce Robinson, Benjamin Solomon, Hyunseok Kang, Jochen Lorch, Francis Worden, Marcia Brose, Jyoti Patel, Sophie Leboulleux,[...]. N Engl J Med 2020
216
45

Efficacy of Selpercatinib in RET Fusion-Positive Non-Small-Cell Lung Cancer.
Alexander Drilon, Geoffrey R Oxnard, Daniel S W Tan, Herbert H F Loong, Melissa Johnson, Justin Gainor, Caroline E McCoach, Oliver Gautschi, Benjamin Besse, Byoung C Cho,[...]. N Engl J Med 2020
253
36

Vandetanib in patients with locally advanced or metastatic medullary thyroid cancer: a randomized, double-blind phase III trial.
Samuel A Wells, Bruce G Robinson, Robert F Gagel, Henning Dralle, James A Fagin, Massimo Santoro, Eric Baudin, Rossella Elisei, Barbara Jarzab, James R Vasselli,[...]. J Clin Oncol 2012
877
36

The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis.
C Eng, D Clayton, I Schuffenecker, G Lenoir, G Cote, R F Gagel, H K van Amstel, C J Lips, I Nishisho, S I Takai,[...]. JAMA 1996
777
27

RET/PTC rearrangements in thyroid nodules: studies in irradiated and not irradiated, malignant and benign thyroid lesions in children and adults.
R Elisei, C Romei, T Vorontsova, B Cosci, V Veremeychik, E Kuchinskaya, F Basolo, E P Demidchik, P Miccoli, A Pinchera,[...]. J Clin Endocrinol Metab 2001
210
27

A comprehensive overview of the role of the RET proto-oncogene in thyroid carcinoma.
Cristina Romei, Raffaele Ciampi, Rossella Elisei. Nat Rev Endocrinol 2016
175
27

Cabozantinib in progressive medullary thyroid cancer.
Rossella Elisei, Martin J Schlumberger, Stefan P Müller, Patrick Schöffski, Marcia S Brose, Manisha H Shah, Lisa Licitra, Barbara Jarzab, Viktor Medvedev, Michael C Kreissl,[...]. J Clin Oncol 2013
685
27

State-of-the-Art Strategies for Targeting RET-Dependent Cancers.
Vivek Subbiah, Dong Yang, Vamsidhar Velcheti, Alexander Drilon, Funda Meric-Bernstam. J Clin Oncol 2020
90
27

Pralsetinib for RET fusion-positive non-small-cell lung cancer (ARROW): a multi-cohort, open-label, phase 1/2 study.
Justin F Gainor, Giuseppe Curigliano, Dong-Wan Kim, Dae Ho Lee, Benjamin Besse, Christina S Baik, Robert C Doebele, Philippe A Cassier, Gilberto Lopes, Daniel S W Tan,[...]. Lancet Oncol 2021
79
27

Pralsetinib for patients with advanced or metastatic RET-altered thyroid cancer (ARROW): a multi-cohort, open-label, registrational, phase 1/2 study.
Vivek Subbiah, Mimi I Hu, Lori J Wirth, Martin Schuler, Aaron S Mansfield, Giuseppe Curigliano, Marcia S Brose, Viola W Zhu, Sophie Leboulleux, Daniel W Bowles,[...]. Lancet Diabetes Endocrinol 2021
77
27

Multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma: an update.
Samuel A Wells, Furio Pacini, Bruce G Robinson, Massimo Santoro. J Clin Endocrinol Metab 2013
184
18

Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma.
Samuel A Wells, Sylvia L Asa, Henning Dralle, Rossella Elisei, Douglas B Evans, Robert F Gagel, Nancy Lee, Andreas Machens, Jeffrey F Moley, Furio Pacini,[...]. Thyroid 2015
988
18

Pattern of radiation-induced RET and NTRK1 rearrangements in 191 post-chernobyl papillary thyroid carcinomas: biological, phenotypic, and clinical implications.
H M Rabes, E P Demidchik, J D Sidorow, E Lengfelder, C Beimfohr, D Hoelzel, S Klugbauer. Clin Cancer Res 2000
254
18

Proximity of chromosomal loci that participate in radiation-induced rearrangements in human cells.
M N Nikiforova, J R Stringer, R Blough, M Medvedovic, J A Fagin, Y E Nikiforov. Science 2000
339
18

Medullary thyroid cancer: management guidelines of the American Thyroid Association.
Richard T Kloos, Charis Eng, Douglas B Evans, Gary L Francis, Robert F Gagel, Hossein Gharib, Jeffrey F Moley, Furio Pacini, Matthew D Ringel, Martin Schlumberger,[...]. Thyroid 2009
823
18


Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A.
L M Mulligan, J B Kwok, C S Healey, M J Elsdon, C Eng, E Gardner, D R Love, S E Mole, J K Moore, L Papi. Nature 1993
18

Overall survival analysis of EXAM, a phase III trial of cabozantinib in patients with radiographically progressive medullary thyroid carcinoma.
M Schlumberger, R Elisei, S Müller, P Schöffski, M Brose, M Shah, L Licitra, J Krajewska, M C Kreissl, B Niederle,[...]. Ann Oncol 2017
96
18

RET rearrangements are actionable alterations in breast cancer.
Bhavna S Paratala, Jon H Chung, Casey B Williams, Bahar Yilmazel, Whitney Petrosky, Kirstin Williams, Alexa B Schrock, Laurie M Gay, Ellen Lee, Sonia C Dolfi,[...]. Nat Commun 2018
58
18

Intracranial Efficacy of Selpercatinib in RET Fusion-Positive Non-Small Cell Lung Cancers on the LIBRETTO-001 Trial.
Vivek Subbiah, Justin F Gainor, Geoffrey R Oxnard, Daniel S W Tan, Dwight H Owen, Byoung Chul Cho, Herbert H Loong, Caroline E McCoach, Jared Weiss, Yu Jung Kim,[...]. Clin Cancer Res 2021
24
18

Molecular heterogeneity of RET loss of function in Hirschsprung's disease.
F Carlomagno, G De Vita, M T Berlingieri, V de Franciscis, R M Melillo, V Colantuoni, M H Kraus, P P Di Fiore, A Fusco, M Santoro. EMBO J 1996
104
18

GFRAL is the receptor for GDF15 and the ligand promotes weight loss in mice and nonhuman primates.
Shannon E Mullican, Xiefan Lin-Schmidt, Chen-Ni Chin, Jose A Chavez, Jennifer L Furman, Anthony A Armstrong, Stephen C Beck, Victoria J South, Thai Q Dinh, Tanesha D Cash-Mason,[...]. Nat Med 2017
333
18

The metabolic effects of GDF15 are mediated by the orphan receptor GFRAL.
Paul J Emmerson, Feng Wang, Yong Du, Qian Liu, Richard T Pickard, Malgorzata D Gonciarz, Tamer Coskun, Matthew J Hamang, Dana K Sindelar, Kimberly K Ballman,[...]. Nat Med 2017
281
18

RET Aberrations in Diverse Cancers: Next-Generation Sequencing of 4,871 Patients.
Shumei Kato, Vivek Subbiah, Erica Marchlik, Sheryl K Elkin, Jennifer L Carter, Razelle Kurzrock. Clin Cancer Res 2017
121
18

Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B.
M Santoro, F Carlomagno, A Romano, D P Bottaro, N A Dathan, M Grieco, A Fusco, G Vecchio, B Matoskova, M H Kraus. Science 1995
705
18

RET revisited: expanding the oncogenic portfolio.
Lois M Mulligan. Nat Rev Cancer 2014
306
18

GFRAL is the receptor for GDF15 and is required for the anti-obesity effects of the ligand.
Linda Yang, Chih-Chuan Chang, Zhe Sun, Dennis Madsen, Haisun Zhu, Søren B Padkjær, Xiaoai Wu, Tao Huang, Karin Hultman, Sarah J Paulsen,[...]. Nat Med 2017
293
18

Tumor-induced anorexia and weight loss are mediated by the TGF-beta superfamily cytokine MIC-1.
Heiko Johnen, Shu Lin, Tamara Kuffner, David A Brown, Vicky Wang-Wei Tsai, Asne R Bauskin, Liyun Wu, Greg Pankhurst, Lele Jiang, Simon Junankar,[...]. Nat Med 2007
373
18

Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC.
H Donis-Keller, S Dou, D Chi, K M Carlson, K Toshima, T C Lairmore, J R Howe, J F Moley, P Goodfellow, S A Wells. Hum Mol Genet 1993
18

Precision Targeted Therapy with BLU-667 for RET-Driven Cancers.
Vivek Subbiah, Justin F Gainor, Rami Rahal, Jason D Brubaker, Joseph L Kim, Michelle Maynard, Wei Hu, Qiongfang Cao, Michael P Sheets, Douglas Wilson,[...]. Cancer Discov 2018
215
18

The MIC-1/GDF15-GFRAL Pathway in Energy Homeostasis: Implications for Obesity, Cachexia, and Other Associated Diseases.
Vicky W W Tsai, Yasmin Husaini, Amanda Sainsbury, David A Brown, Samuel N Breit. Cell Metab 2018
162
18

Kinase fusions are frequent in Spitz tumours and spitzoid melanomas.
Thomas Wiesner, Jie He, Roman Yelensky, Rosaura Esteve-Puig, Thomas Botton, Iwei Yeh, Doron Lipson, Geoff Otto, Kristina Brennan, Rajmohan Murali,[...]. Nat Commun 2014
379
18

Mechanism of activation of the ret proto-oncogene by multiple endocrine neoplasia 2A mutations.
N Asai, T Iwashita, M Matsuyama, M Takahashi. Mol Cell Biol 1995
315
18

Molecular Profiling of Salivary Gland Intraductal Carcinoma Revealed a Subset of Tumors Harboring NCOA4-RET and Novel TRIM27-RET Fusions: A Report of 17 cases.
Alena Skálová, Tomas Vanecek, Emmanuelle Uro-Coste, Justin A Bishop, Ilan Weinreb, Lester D R Thompson, Stefano de Sanctis, Marco Schiavo-Lena, Jan Laco, Cécile Badoual,[...]. Am J Surg Pathol 2018
73
18

A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma.
R M Hofstra, R M Landsvater, I Ceccherini, R P Stulp, T Stelwagen, Y Luo, B Pasini, J W Höppener, H K van Amstel, G Romeo. Nature 1994
948
18

Structure and physiology of the RET receptor tyrosine kinase.
Carlos F Ibáñez. Cold Spring Harb Perspect Biol 2013
101
18


Mutations of the RET proto-oncogene in Hirschsprung's disease.
P Edery, S Lyonnet, L M Mulligan, A Pelet, E Dow, L Abel, S Holder, C Nihoul-Fékété, B A Ponder, A Munnich. Nature 1994
648
18

GDF15 Is an Inflammation-Induced Central Mediator of Tissue Tolerance.
Harding H Luan, Andrew Wang, Brandon K Hilliard, Fernando Carvalho, Connor E Rosen, Amy M Ahasic, Erica L Herzog, Insoo Kang, Margaret A Pisani, Shuang Yu,[...]. Cell 2019
190
18

RET/PTC rearrangements preferentially occurred in papillary thyroid cancer among atomic bomb survivors exposed to high radiation dose.
Kiyohiro Hamatani, Hidetaka Eguchi, Reiko Ito, Mayumi Mukai, Keiko Takahashi, Masataka Taga, Kazue Imai, John Cologne, Midori Soda, Koji Arihiro,[...]. Cancer Res 2008
113
18

Non-homeostatic body weight regulation through a brainstem-restricted receptor for GDF15.
Jer-Yuan Hsu, Suzanne Crawley, Michael Chen, Dina A Ayupova, Darrin A Lindhout, Jared Higbee, Alan Kutach, William Joo, Zhengyu Gao, Diana Fu,[...]. Nature 2017
259
18

RET fusion genes are associated with chronic myelomonocytic leukemia and enhance monocytic differentiation.
P Ballerini, S Struski, C Cresson, N Prade, S Toujani, C Deswarte, S Dobbelstein, A Petit, H Lapillonne, E-F Gautier,[...]. Leukemia 2012
67
18

ret/PTC-1 Activation in Hashimoto Thyroiditis.
O. M. Sheils, J.J. O'eary, V. Uhlmann, K. Lättich, E. C. Sweeney. Int J Surg Pathol 2000
98
9

The RNA component of human telomerase.
J Feng, W D Funk, S S Wang, S L Weinrich, A A Avilion, C P Chiu, R R Adams, E Chang, R C Allsopp, J Yu. Science 1995
9

Association of high iodine intake with the T1799A BRAF mutation in papillary thyroid cancer.
Haixia Guan, Meiju Ji, Rong Bao, Hongyu Yu, Yangang Wang, Peng Hou, Yong Zhang, Zhongyan Shan, Weiping Teng, Mingzhao Xing. J Clin Endocrinol Metab 2009
153
9

Papillary thyroid cancer incidence in the volcanic area of Sicily.
Gabriella Pellegriti, Florent De Vathaire, Claudia Scollo, Marco Attard, Carla Giordano, Salvatore Arena, Gabriella Dardanoni, Francesco Frasca, Pasqualino Malandrino, Francesco Vermiglio,[...]. J Natl Cancer Inst 2009
105
9

The changing characteristics and molecular profiles of papillary thyroid carcinoma over time: a systematic review.
Huy Gia Vuong, Ahmed M A Altibi, Amr Hesham Abdelhamid, Phuong Uyen Duong Ngoc, Vo Duy Quan, Mohamed Yousef Tantawi, Mohamed Elfil, Tran Le Huy Vu, Ahmed Elgebaly, Naoki Oishi,[...]. Oncotarget 2017
44
9

Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies.
Eleonora Molinaro, Cristina Romei, Agnese Biagini, Elena Sabini, Laura Agate, Salvatore Mazzeo, Gabriele Materazzi, Stefano Sellari-Franceschini, Alessandro Ribechini, Liborio Torregrossa,[...]. Nat Rev Endocrinol 2017
211
9

The primary occurrence of BRAF(V600E) is a rare clonal event in papillary thyroid carcinoma.
Anna Guerra, Maria Rosaria Sapio, Vincenzo Marotta, Elisabetta Campanile, Stefania Rossi, Irene Forno, Laura Fugazzola, Alfredo Budillon, Tania Moccia, Gianfranco Fenzi,[...]. J Clin Endocrinol Metab 2012
117
9

Oncogenic AKAP9-BRAF fusion is a novel mechanism of MAPK pathway activation in thyroid cancer.
Raffaele Ciampi, Jeffrey A Knauf, Roswitha Kerler, Manoj Gandhi, Zhaowen Zhu, Marina N Nikiforova, Hartmut M Rabes, James A Fagin, Yuri E Nikiforov. J Clin Invest 2005
313
9


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.